152 related articles for article (PubMed ID: 10093860)
1. Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.
Satta J; Ahonen A; Parkkila S; Leinonen L; Apaja-Sarkkinen M; Lepojärvi M; Juvonen T
Scand Cardiovasc J; 1999; 33(1):49-53. PubMed ID: 10093860
[TBL] [Abstract][Full Text] [Related]
2. Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue.
Cadigan DG; Hollett PD; Collingwood PW; Ur E
Clin Nucl Med; 1996 Jun; 21(6):487-8. PubMed ID: 8744192
[No Abstract] [Full Text] [Related]
3. [Gammagraphy of somatostatin receptors in an ACTH secreting thymic carcinoid].
Banzo J; Razola P; Prats E; Freile E; Benito JL; García López F; García Tirado J; Abós MD
Rev Esp Med Nucl; 1999; 18(2):99-103. PubMed ID: 10352322
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
5. [Isotopic scan with somatostatin receptors in a case of recurrent carcinoid tumor. Relevance of tomographic detection].
Bernà Roqueta L; Martín Marimón JC; Martín Martínez J
Rev Esp Med Nucl; 2002 Apr; 21(2):123-4. PubMed ID: 11879622
[No Abstract] [Full Text] [Related]
6. Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging.
Silva F; Vázquez-Sellés J; Aguilö F; Vázquez G; Flores C
Clin Nucl Med; 1999 Feb; 24(2):109-10. PubMed ID: 9988068
[TBL] [Abstract][Full Text] [Related]
7. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
[TBL] [Abstract][Full Text] [Related]
9. Current role of 111In-DTPA-octreotide scintigraphy in diagnosis of thymic masses.
Guidoccio F; Grosso M; Maccauro M; Orsini F; Perri M; Boni G; Banti E; Grassetto G; Rubello D; Mariani G; Volterrani D
Tumori; 2011; 97(2):191-5. PubMed ID: 21617714
[TBL] [Abstract][Full Text] [Related]
10. An unusual case of multiple endocrine neoplasia type 1 and the role of 111In-pentetreotide scintigraphy.
Ponssen HH; de Herder WW; Bonjer HJ; Wauters CC; Krenning EP; Lamberts SW
Neth J Med; 1996 Sep; 49(3):112-5. PubMed ID: 8854674
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.
Westlin JE; Janson ET; Arnberg H; Ahlström H; Oberg K; Nilsson S
Acta Oncol; 1993; 32(7-8):783-6. PubMed ID: 8305227
[TBL] [Abstract][Full Text] [Related]
12. Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1.
Burgess JR; Giles N; Shepherd JJ
Clin Endocrinol (Oxf); 2001 Nov; 55(5):689-93. PubMed ID: 11894982
[TBL] [Abstract][Full Text] [Related]
13. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
15. Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study.
Gibril F; Reynolds JC; Lubensky IA; Roy PK; Peghini PL; Doppman JL; Jensen RT
J Nucl Med; 2000 Oct; 41(10):1646-56. PubMed ID: 11037994
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.
Gibril F; Chen YJ; Schrump DS; Vortmeyer A; Zhuang Z; Lubensky IA; Reynolds JC; Louie A; Entsuah LK; Huang K; Asgharian B; Jensen RT
J Clin Endocrinol Metab; 2003 Mar; 88(3):1066-81. PubMed ID: 12629087
[TBL] [Abstract][Full Text] [Related]
17. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.
Ferolla P; Falchetti A; Filosso P; Tomassetti P; Tamburrano G; Avenia N; Daddi G; Puma F; Ribacchi R; Santeusanio F; Angeletti G; Brandi ML
J Clin Endocrinol Metab; 2005 May; 90(5):2603-9. PubMed ID: 15713725
[TBL] [Abstract][Full Text] [Related]
18. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor scintigraphy in patients with carcinoid tumors.
Kwekkeboom DJ; Krenning EP
World J Surg; 1996 Feb; 20(2):157-61. PubMed ID: 8661811
[TBL] [Abstract][Full Text] [Related]
20. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
